How to buy Synaptogenix stock (SNPX)

Synaptogenix is a biotechnology business based in the US. Synaptogenix shares (SNPX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.07 – an increase of 14.13% over the previous week. Synaptogenix employs 5 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Synaptogenix stock

Buy Synaptogenix stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Synaptogenix stock price (NASDAQ: SNPX)

Use our graph to track the performance of SNPX stocks over time.

Synaptogenix shares at a glance

• Key figures

Information last updated 2024-12-15.

Latest market close	$3.07
52-week range	$2.32 - $8.78
50-day moving average more info button	$3.13
200-day moving average more info button	$4.13
Wall St. target price	$14.00
PE ratio more info button	0.2921
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$10.27

Is it a good time to buy Synaptogenix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Synaptogenix price performance over time

Historical closes compared with the close of $2.565 from 2024-12-19

1 week (2024-12-13)	-4.65%
1 month (2024-11-21)	2.565
3 months (2024-09-20)	-23.20%
6 months (2024-06-21)	-39.36%

1 year (2023-12-21)	850.00%
2 years (2022-12-20)	-89.94%
3 years (2021-12-21)	221.5
5 years (2019-12-17)	N/A

Is Synaptogenix stock undervalued or overvalued?

Valuing Synaptogenix stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Synaptogenix's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Synaptogenix's P/E ratio

Synaptogenix's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 0x. In other words, Synaptogenix shares trade at around 0x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Synaptogenix financials

Gross profit TTM	$0
Return on assets TTM	-13.82%
Return on equity TTM	-7.5%
Profit margin	0%
Book value	$14.99
Market Capitalization more info button	$4.1 million

TTM: trailing 12 months

Synaptogenix share dividends

We're not expecting Synaptogenix to pay a dividend over the next 12 months.

Have Synaptogenix's shares ever split?

Synaptogenix's shares were split on a 1:25 basis on 4 April 2024 . So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Synaptogenix shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Synaptogenix shares which in turn could have impacted Synaptogenix's share price.

Synaptogenix share price volatility

Over the last 12 months, Synaptogenix's shares have ranged in value from as little as $2.32 up to $8.775. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Synaptogenix's is 1.427. This would suggest that Synaptogenix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Synaptogenix overview

Synaptogenix, Inc. operates as a clinical-stage biopharmaceutical company. It is conducting clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Its preclinical studies have also demonstrated bryostatin's regenerative mechanisms of action for the rare disease Fragile X syndrome, and for other neurodegenerative disorders, such as multiple sclerosis, stroke, and traumatic brain injury. The U. S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome.

Frequently asked questions

What percentage of Synaptogenix is owned by insiders or institutions?
Currently 1.949% of Synaptogenix shares are held by insiders and 0.293% by institutions. How many people work for Synaptogenix?
Latest data suggests 5 work at Synaptogenix. When does the fiscal year end for Synaptogenix?
Synaptogenix's fiscal year ends in December. Where is Synaptogenix based?
Synaptogenix's address is: 1185 Avenue of the Americas, New York, NY, United States, 10036 What is Synaptogenix's ISIN number?
Synaptogenix's international securities identification number is: US87167T2015